Results 31 to 40 of about 313,837 (264)
Critical evaluation of asthma biomarkers in clinical practice
Frontiers in Medicine, 2022 The advent of personalized medicine has revolutionized the whole approach to the management of asthma, representing the essential basis for future developments.
Giuseppe Guida +14 more
doaj +1 more source
Pharmacotherapy of severe asthma [PDF]
Current Opinion in Pharmacology, 2010 Severe asthma is a complex and heterogeneous phenotype where management can be challenging. While many patients with severe asthma respond to high-dose inhaled corticosteroids in combination with a long-acting beta-agonist, there remains a significant subset of patients that require oral corticosteroids to control symptoms.
Rafael, Firszt, Monica, Kraft
openaire +2 more sources
Journal of Respiration, 2023 Introduction: Asthma and bronchiectasis are often partners in a complex but uneven relationship with asthma receiving more attention. The aim of this study is to describe how bronchiectasis is investigated in some Severe Asthma (SA) Centers, scattered ...
Giovanna Elisiana Carpagnano +10 more
doaj +1 more source
Severity of chronic asthma [PDF]
Thorax, 1998 How is the severity of chronic asthma best assessed and what are the mechanisms that determine its severity? These two questions are difficult to answer because, until we understand what asthma is, it is not possible to describe its severity in a given individual.
A J, Woolcock, D, Dusser, I, Fajac
openaire +2 more sources
BMJ Open, 2020 Objectives Severe asthma imposes a significant burden on individuals, families and the healthcare system. New treatment and management approaches are emerging as effective options for severe asthma.
Peter G Gibson +13 more
doaj +1 more source
Azithromycin and severe asthma [PDF]
Thorax, 2013 Brusselle et al 1 performed an interesting academic-based randomised controlled trial Azithromycin for Prevention of Exacerbations in Severe Asthma (AZISAST) of azithromycin 250 mgm taken thrice weekly versus placebo as add-on therapy for 26 weeks in non-smoking patients with severe asthma, defined as Global Initiative for Asthma (GINA) steps 4–5 ...
openaire +2 more sources
Pathophysiology of severe asthma [PDF]
Journal of Allergy and Clinical Immunology, 2000 Although asthma affects nearly 8% of the adult population, most of these patients have mild-to-moderate disease that can be controlled with appropriate treatment. It is estimated, however, that 5% to 10% of patients with asthma have severe disease that is unresponsive to typical therapeutics, including corticosteroids.
W W, Busse +2 more
openaire +2 more sources
Annals of MedicineBackground Some patients with severe asthma may benefit from treatment with biologics, but evidence has been mostly collected from randomized controlled trials (RCTs), in which patients’ characteristics are different from those encountered in asthma ...
Maria Basagaña +12 more
doaj +1 more source
Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
Respirology Case Reports, 2021 Severe asthma can be associated with eosinophilic or allergic phenotypes or both. Eosinophilic inflammation is associated with exacerbations and disease severity due to biological activity of interleukin‐5 (IL‐5).
Venkata Nagarjuna Maturu +7 more
doaj +1 more source
Asthma heterogeneity and severity [PDF]
World Allergy Organization Journal, 2016 Asthma is a common, chronic inflammatory airways disease characterized by a clinical syndrome of bronchial hyperresponsiveness, inflammation, and reversible airflow obstruction. Individuals with asthma can vary widely in clinical presentation, severity, and pathobiology.
Tara F. Carr, Eugene Bleecker
openaire +3 more sources